about
Optimization of the Expression of Human Aldehyde Oxidase for Investigations of Single-Nucleotide PolymorphismsThe impact of single nucleotide polymorphisms on human aldehyde oxidaseXanthine dehydrogenase and 2-furoyl-coenzyme A dehydrogenase from Pseudomonas putida Fu1: two molybdenum-containing dehydrogenases of novel structural compositionMechanism of porcine liver xanthine oxidoreductase mediated N-oxide reduction of cyadox as revealed by docking and mutagenesis studiesThe fourth mammalian molybdenum enzyme mARC: current state of research.Molybdenum: an essential trace element.Physiological roles of xanthine oxidoreductase.Metabolism of azo dyes: implication for detoxication and activation.Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions-an Industry Perspective.Chemical reactivity considerations in the metabolism of N-heteroaromatics.Contribution of amine oxidases to the metabolism of xenobiotics.Metabolic oxidation of the pyrrole ring: structure and origin of some urinary metabolites of the anti-hypertensive pyrrolylpyridazinamine, mopidralazine. III: Studies with the 13C-labelled drug.Expression of xanthine oxidoreductase in mouse mammary epithelium during pregnancy and lactation: regulation of gene expression by glucocorticoids and prolactin.Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase.Enzymatic and non-enzymatic reduction of brucine N-oxide by aldehyde oxidase and catalase.Similarity in the aldehyde oxidases from guinea-pig liver and polymorphonuclear leucocytes.In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor.Species differences in metabolism of ripasudil (K-115) are attributed to aldehyde oxidase.Stereospecific oxidation of the (S)-enantiomer of RS-8359, a selective and reversible monoamine oxidase A (MAO-A) inhibitor, by aldehyde oxidase.Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the Commission related to Flavouring Group Evaluation 17 (FGE.17): Pyrazine derivatives from chemical group ...Flavouring Group Evaluation 17, Revision 1 (FGE.17Rev1): Pyrazine derivatives from chemical group 24 - Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in contact with Food (AFC)Scientific Opinion on Flavouring Group Evaluation 17, Revision 2 (FGE.17Rev2): Pyrazine derivatives from chemical group 24Scientific Opinion on Flavouring Group Evaluation 17, Revision 3 (FGE.17Rev3): Pyrazine derivatives from chemical group 24Heredity mode of genetic polymorphism in aldehyde oxidase activity in Donryu strain rats.Catalytic bio–chemo and bio–bio tandem oxidation reactions for amide and carboxylic acid synthesis
P2860
Q27703955-7DFE63B1-25B5-4DF3-8022-264A02AB1CA0Q28258167-1F5547B4-46EB-4788-95CA-4EEA58E65C52Q28330681-ACBB8397-271E-43AE-97F2-9A975E36319BQ28536938-5FBFDBFD-F8EC-48B8-8268-53B99FF519D7Q34028677-2ADA34A4-1776-4252-800F-3D00B558E096Q34349198-6C8EBAA4-2134-4540-901C-6DCDF2D3AAE7Q35828041-CA634150-B8EA-4C11-A843-CA7E6A265DB2Q37437836-5F56687E-774E-416B-B1E7-83FD0E67C136Q38170468-B49F4F20-44AF-4F19-BF65-AAC61D51B470Q38800092-D93C10BA-ECDF-4AE9-A24F-8DDC23135FD8Q39613476-147DF0DD-9180-4A8F-BF97-CDF366089FB2Q40632139-952BE2DF-C140-491C-AFB3-66A42D60E166Q42218780-B2D3475B-8910-4878-B212-2E9D5B7BFE93Q42984363-E17F39F8-5C78-4D64-98DC-EB9C1E89029CQ43746030-FD60399A-88BB-4B58-83C9-616B675700AFQ43838741-53E18102-2888-4725-94A4-333D918DD32BQ46162210-84AD878E-E524-4EF0-B9A6-25C27EC0672AQ46399560-88C552C7-F395-40C1-8BFF-72BDDB581631Q46622705-63AAB468-1544-45C3-946D-C97E63C5F5F1Q46726519-64AA3E91-6DF4-4AB8-8FF6-15AF105FF1ACQ47144148-E1C58E13-FE97-4898-AAE8-48FC3903A211Q47145745-7B8796D6-DC36-4B44-868F-B6069DC7BAD0Q47149899-401F11A6-AC17-4A0C-9974-2D5C1608F6CAQ47150838-29BA470C-9383-4B21-80F9-4CE8DE9CB6E2Q51722437-B0D06E54-6279-4FB6-8D01-AF7AF0696FF6Q58048609-C3DF5E6F-65D9-4F97-A95D-9B43FC055257
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Molybdenum hydroxylases as drug-metabolizing enzymes.
@en
Molybdenum hydroxylases as drug-metabolizing enzymes.
@nl
type
label
Molybdenum hydroxylases as drug-metabolizing enzymes.
@en
Molybdenum hydroxylases as drug-metabolizing enzymes.
@nl
prefLabel
Molybdenum hydroxylases as drug-metabolizing enzymes.
@en
Molybdenum hydroxylases as drug-metabolizing enzymes.
@nl
P2860
P1476
Molybdenum hydroxylases as drug-metabolizing enzymes.
@en
P2093
P2860
P304
P356
10.3109/03602538508991432
P407
P577
1985-01-01T00:00:00Z